{"id":"booster-vaccination","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or swelling"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Booster vaccinations work by re-exposing the immune system to antigen(s) from a pathogen, triggering rapid proliferation of existing memory immune cells and generating higher-affinity antibodies and stronger T-cell responses than the primary vaccination series alone. This restores or maintains protective immunity levels that may have waned over time, particularly important for diseases where immunity naturally declines or where sustained protection is critical for public health.","oneSentence":"A booster vaccination reinforces and enhances the immune response by stimulating memory B and T cells to increase antibody production and cellular immunity against a previously encountered pathogen.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:41:49.243Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Booster vaccination for infectious disease prevention (specific pathogen dependent on formulation)"}]},"trialDetails":[{"nctId":"NCT04317716","phase":"NA","title":"A Self-management Program to Prevent Falls in People With Multiple Sclerosis","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2022-02-11","conditions":"Multiple Sclerosis","enrollment":45},{"nctId":"NCT06941831","phase":"NA","title":"Rwanda Digital Dashboard Hybrid Type 3 Implementation Study","status":"RECRUITING","sponsor":"Boston College","startDate":"2025-01-30","conditions":"IPV, Mental Health, Discipline Practices","enrollment":1810},{"nctId":"NCT07488559","phase":"NA","title":"Engage Coaching (R33 Phase)","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-05-15","conditions":"Social Connection, Loneliness, Suicide Ideation","enrollment":120},{"nctId":"NCT03387553","phase":"EARLY_PHASE1","title":"HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2018-06-06","conditions":"Breast Cancer, Breast Cancer Female, Breast Cancer, Male","enrollment":31},{"nctId":"NCT07169617","phase":"PHASE2","title":"Testing the SurVaxM Vaccine for Lung Cancer Prevention","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-02-25","conditions":"Lung Carcinoma","enrollment":80},{"nctId":"NCT04235816","phase":"PHASE3","title":"Improving Care Through Azithromycin Research for Infants in Africa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Barcelona Institute for Global Health","startDate":"2021-03-15","conditions":"Child Mortality","enrollment":20560},{"nctId":"NCT07221162","phase":"PHASE1","title":"A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-12-05","conditions":"COVID-19","enrollment":140},{"nctId":"NCT06962111","phase":"NA","title":"Early-Stage Partner in Care Living Alone Plus","status":"RECRUITING","sponsor":"Arizona State University","startDate":"2025-03-26","conditions":"Dementia, Mild Cognitive Impairment (MCI), Alzheimer Disease","enrollment":70},{"nctId":"NCT07183709","phase":"PHASE1","title":"Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-02-02","conditions":"COVID-19","enrollment":60},{"nctId":"NCT02568566","phase":"PHASE2","title":"Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-05-19","conditions":"Human Papillomavirus-Related Carcinoma","enrollment":201},{"nctId":"NCT06496230","phase":"EARLY_PHASE1","title":"Open Trial of Technology-Enhanced Behavioral Intervention for Buprenorphine Retention in Pregnant and Postpartum People","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2024-08-06","conditions":"Opioid Use Disorder, Pregnancy Related","enrollment":15},{"nctId":"NCT07366346","phase":"NA","title":"Telehealth-Adapted Compensatory Training and Intervention for Cognition","status":"NOT_YET_RECRUITING","sponsor":"University of Florida","startDate":"2026-04","conditions":"MCI, Mild Cognitive Impairment, Mild Cognitive Impairment (MCI)","enrollment":100},{"nctId":"NCT04368728","phase":"PHASE2, PHASE3","title":"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2020-04-29","conditions":"SARS-CoV-2 Infection, COVID-19","enrollment":46969},{"nctId":"NCT05265065","phase":"PHASE3","title":"Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-05-27","conditions":"COVID-19","enrollment":601},{"nctId":"NCT07336238","phase":"PHASE2","title":"Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies","status":"RECRUITING","sponsor":"University of Washington","startDate":"2026-04-15","conditions":"Anxiety, Depression, Hematopoietic and Lymphatic System Neoplasm","enrollment":18},{"nctId":"NCT04533763","phase":"NA","title":"Living WELL: A Web-Based Program for Ovarian Cancer Survivors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Susan Lutgendorf","startDate":"2020-09-30","conditions":"Ovarian Cancer","enrollment":326},{"nctId":"NCT05392075","phase":"","title":"COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2023-03-15","conditions":"COVID-19 Pneumonia, COVID-19","enrollment":100},{"nctId":"NCT05992935","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age","status":"RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2023-08-25","conditions":"Norovirus Acute Gastroenteritis","enrollment":1405},{"nctId":"NCT07487077","phase":"PHASE4","title":"Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya","status":"RECRUITING","sponsor":"Albert B. Sabin Vaccine Institute","startDate":"2025-10-31","conditions":"Cholera Vaccination","enrollment":1071},{"nctId":"NCT07419230","phase":"NA","title":"Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project","status":"RECRUITING","sponsor":"Fundación de Investigación Biomédica - Hospital Universitario de La Princesa","startDate":"2026-03-11","conditions":"Allergic Rhinitis","enrollment":880},{"nctId":"NCT05283902","phase":"","title":"Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly","status":"COMPLETED","sponsor":"Federal University of Espirito Santo","startDate":"2022-03-19","conditions":"COVID-19, Vaccine Adverse Reaction, Vaccine-Preventable Diseases","enrollment":260},{"nctId":"NCT07308613","phase":"NA","title":"Developing and Testing a Machine Learning Enabled Mindfulness Intervention for Reducing Loneliness Among Hong Kong Chinese Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Education University of Hong Kong","startDate":"2026-05-01","conditions":"Loneliness","enrollment":250},{"nctId":"NCT06170047","phase":"NA","title":"Chicago Parent Program for Foster and Kinship Caregivers","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2024-02-02","conditions":"Behavior Problem, Parenting","enrollment":300},{"nctId":"NCT07483333","phase":"NA","title":"Comparative Effectiveness of SPARCS and Unified Protocol for Youth With Chronic Medical Conditions and Trauma-Related Distress","status":"NOT_YET_RECRUITING","sponsor":"Anthony Vesco","startDate":"2026-07","conditions":"Trauma Exposure, Trauma, Trauma and Stressor Related Disorder","enrollment":400},{"nctId":"NCT06312553","phase":"NA","title":"Remotely Delivered Mindfulness-Based Diabetes Education","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Type 2 Diabetes","enrollment":80},{"nctId":"NCT05131074","phase":"NA","title":"Collabree: A Remote Intervention to Improve the Regularity of Medication Intake","status":"COMPLETED","sponsor":"Anjali Raja Beharelle","startDate":"2022-03-10","conditions":"Hypertension, Medication Adherence","enrollment":144},{"nctId":"NCT07190404","phase":"NA","title":"Multicontext Approach for Cognitive Function in Parkinson Disease","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-04-22","conditions":"PARKINSON DISEASE (Disorder)","enrollment":114},{"nctId":"NCT04708756","phase":"NA","title":"Collabree: An Intervention to Improve the Regularity of Medication Intake","status":"COMPLETED","sponsor":"Collabree AG","startDate":"2021-07-01","conditions":"Hypertension, Medication Adherence","enrollment":181},{"nctId":"NCT06624332","phase":"NA","title":"Home Visitation Enhancing Linkages Project in Kansas","status":"NOT_YET_RECRUITING","sponsor":"The National Center on Addiction and Substance Abuse at Columbia University","startDate":"2026-06-01","conditions":"Substance Use","enrollment":120},{"nctId":"NCT07083479","phase":"","title":"Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma","status":"AVAILABLE","sponsor":"Elicio Therapeutics","startDate":"","conditions":"Pancreatic Ductal Adenocarcinoma, KRAS G12D, KRAS G12V","enrollment":""},{"nctId":"NCT07478250","phase":"NA","title":"First Responder Safety Training (FiRST)","status":"NOT_YET_RECRUITING","sponsor":"Stony Brook University","startDate":"2026-04-01","conditions":"Resilience and Mental Health of First Responders","enrollment":800},{"nctId":"NCT05726864","phase":"PHASE1, PHASE2","title":"A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Elicio Therapeutics","startDate":"2023-04-14","conditions":"Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, KRAS G12D","enrollment":158},{"nctId":"NCT06864715","phase":"NA","title":"Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2026-04-01","conditions":"Post-stroke Depression, Subthreshold Depression","enrollment":294},{"nctId":"NCT05634876","phase":"PHASE1","title":"UB-312 in Patients With Synucleinopathies","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2023-05-31","conditions":"Multiple System Atrophy, Parkinson Disease","enrollment":8},{"nctId":"NCT05683457","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.","status":"RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2023-04-05","conditions":"Cytomegalovirus Infection","enrollment":224},{"nctId":"NCT04936529","phase":"PHASE2","title":"A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-08-02","conditions":"Neuroblastoma","enrollment":286},{"nctId":"NCT06181643","phase":"NA","title":"Innovating CBT-I for Cancer Survivors: An Optimization Trial","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-09-06","conditions":"Cancer Survivorship, Insomnia","enrollment":80},{"nctId":"NCT07414238","phase":"NA","title":"Effect of Vibration and Non-Vibration Foam Rolling","status":"COMPLETED","sponsor":"Celal Bayar University","startDate":"2026-02-10","conditions":"Self-Myofascial Release","enrollment":14},{"nctId":"NCT06807086","phase":"NA","title":"Efficacy of Synchronous, Virtual Cognitive Behavioral Therapy for Insomnia Across Phases of Cancer Survivorship","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-01-01","conditions":"Insomnia Chronic","enrollment":198},{"nctId":"NCT02287428","phase":"PHASE1","title":"Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2014-11","conditions":"Glioblastoma","enrollment":56},{"nctId":"NCT07145983","phase":"NA","title":"Effect of Peer Support Intervention on Medication Adherence, Self-care and Knowledge Among Patients With Diabetes","status":"COMPLETED","sponsor":"Addis Ababa University","startDate":"2024-12-01","conditions":"Peer Influence, Medication Adherence, Self Care","enrollment":120},{"nctId":"NCT06134648","phase":"PHASE1, PHASE2","title":"Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2023-11-01","conditions":"Respiratory Syncytial Virus Infection, Healthy Volunteers, Human Metapneumovirus","enrollment":646},{"nctId":"NCT06181292","phase":"PHASE2, PHASE3","title":"Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine","status":"COMPLETED","sponsor":"Hipra Scientific, S.L.U","startDate":"2023-11-15","conditions":"SARS-CoV2 Infection","enrollment":913},{"nctId":"NCT06234956","phase":"PHASE2","title":"Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.","status":"COMPLETED","sponsor":"Hipra Scientific, S.L.U","startDate":"2023-06-08","conditions":"SARS CoV 2 Infection","enrollment":242},{"nctId":"NCT06528067","phase":"NA","title":"Mindful Motivation for Reducing Binge Eating","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-08-01","conditions":"Binge Eating, Psychological, Health Behavior","enrollment":100},{"nctId":"NCT05142553","phase":"PHASE2","title":"Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.","status":"COMPLETED","sponsor":"Hipra Scientific, S.L.U","startDate":"2021-11-16","conditions":"COVID-19, SARS-CoV-2 Acute Respiratory Disease","enrollment":887},{"nctId":"NCT06599658","phase":"PHASE2","title":"COVID-19 Booster and IIV Schedule in Immunocompromised Hosts","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2024-11-20","conditions":"COVID 19, Influenza, Rheumatoid Arthritis (RA)","enrollment":660},{"nctId":"NCT06639607","phase":"PHASE1, PHASE2","title":"PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-04-30","conditions":"Diffuse Midline Glioma, Diffuse Midline High-grade Glioma, Medulloblastoma","enrollment":68},{"nctId":"NCT07463001","phase":"NA","title":"Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Municipalities","status":"NOT_YET_RECRUITING","sponsor":"Norwegian University of Science and Technology","startDate":"2026-03-23","conditions":"School Attendance Problems","enrollment":240},{"nctId":"NCT03219190","phase":"NA","title":"A High School Program for Preventing Prescription Drug Misuse","status":"COMPLETED","sponsor":"National Health Promotion Associates, Inc.","startDate":"2022-02-01","conditions":"Prescription Drug Abuse, Substance Abuse, Substance Use (Drugs, Alcohol)","enrollment":1804},{"nctId":"NCT07103148","phase":"PHASE3","title":"A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-07-11","conditions":"Yellow Fever Immunization","enrollment":2440},{"nctId":"NCT04055948","phase":"NA","title":"Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2019-12-17","conditions":"Cancer","enrollment":484},{"nctId":"NCT06096519","phase":"NA","title":"Effectiveness and Implementation of Text Messaging to Improve HIV Testing in Adolescents","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2024-06-13","conditions":"HIV","enrollment":360},{"nctId":"NCT07112053","phase":"PHASE2","title":"A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-11-17","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast Carcinoma","enrollment":40},{"nctId":"NCT04230395","phase":"NA","title":"Alcohol Reduction Among People With TB and HIV in India","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-09-22","conditions":"Tuberculosis, HIV","enrollment":450},{"nctId":"NCT06254326","phase":"PHASE1","title":"ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2024-09-19","conditions":"Recurrent Oligodendroglioma, Progressive Oligodendroglioma","enrollment":12},{"nctId":"NCT05889624","phase":"NA","title":"Responding With Evidence and Access for Childhood Headaches","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-08-22","conditions":"Headache, Headache Disorders, Headache, Migraine","enrollment":400},{"nctId":"NCT07455318","phase":"PHASE3","title":"Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2026-05-15","conditions":"Rabies (Healthy Volunteers)","enrollment":561},{"nctId":"NCT03384914","phase":"PHASE2","title":"Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2018-02-19","conditions":"Breast Cancer Female, Breast Cancer, Male, Breast Cancer Stage I","enrollment":119},{"nctId":"NCT06375265","phase":"NA","title":"Digital Sleep Optimization for Brain Health Outcomes in Older Surgical Patients","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-01-15","conditions":"Insomnia, Postoperative Delirium, Delayed Neurocognitive Recovery","enrollment":50},{"nctId":"NCT05672355","phase":"PHASE2","title":"A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2023-08-01","conditions":"Chronic Lymphocytic Leukemia, COVID-19 Infection","enrollment":80},{"nctId":"NCT05935176","phase":"PHASE4","title":"Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)","status":"ACTIVE_NOT_RECRUITING","sponsor":"CanSino Biologics Inc.","startDate":"2023-09-20","conditions":"Epidemic Meningitis","enrollment":660},{"nctId":"NCT06982820","phase":"NA","title":"Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia","status":"RECRUITING","sponsor":"GrayMatters Health Ltd.","startDate":"2025-06-25","conditions":"Depressive Disorder, Major","enrollment":170},{"nctId":"NCT07051031","phase":"PHASE4","title":"COVID-19 Reactogenicity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Marcel Curlin","startDate":"2025-10-01","conditions":"COVID-19","enrollment":1000},{"nctId":"NCT07444866","phase":"NA","title":"Machine Learning Enabled Management of Behavioural and Psychological Symptoms of Dementia Intervention for Dementia Caregivers","status":"NOT_YET_RECRUITING","sponsor":"Education University of Hong Kong","startDate":"2026-06-01","conditions":"Dementia Caregiver","enrollment":500},{"nctId":"NCT07446231","phase":"NA","title":"Reframing Retirement: An Examination of Identity Change and Self-Regulation Approaches to Promote Physical Activity","status":"NOT_YET_RECRUITING","sponsor":"University of Victoria","startDate":"2026-03-01","conditions":"Physical Activity, Health Promotion","enrollment":159},{"nctId":"NCT06809335","phase":"NA","title":"A Pilot of a Personalized Circadian mHealth to Improve Sleep in Night Shift Workers","status":"RECRUITING","sponsor":"Henry Ford Health System","startDate":"2023-10-23","conditions":"Shift Work Sleep Disorder","enrollment":300},{"nctId":"NCT07443709","phase":"PHASE2","title":"Zoster Vaccine to Enhance Protection Against Zoster in Solid-organ Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Oriol Manuel","startDate":"2026-04","conditions":"Zoster; Herpes","enrollment":75},{"nctId":"NCT05934019","phase":"NA","title":"Efficacy of a Transdiagnostic Online Prevention Approach in Adolescents (EMPATIA)","status":"COMPLETED","sponsor":"University of Bern","startDate":"2023-06-09","conditions":"Mental Health Issue, Transdiagnostic Mechanisms, Adolescent Psychology","enrollment":158},{"nctId":"NCT07017777","phase":"PHASE3","title":"A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)","status":"RECRUITING","sponsor":"CanSino Biologics Inc.","startDate":"2025-11-14","conditions":"Pneumococcal Infections, Streptococcal Infections, Bacterial Infections","enrollment":600},{"nctId":"NCT05304078","phase":"NA","title":"Telehealth Assessment and Skill-Building Intervention for Stroke Caregivers (TASK III)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cincinnati","startDate":"2022-11-30","conditions":"Family Caregivers, Stroke","enrollment":332},{"nctId":"NCT07417488","phase":"PHASE1","title":"GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas","status":"NOT_YET_RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2026-02","conditions":"Colorectal Cancer, Small Bowel Adenocarcinoma","enrollment":18},{"nctId":"NCT06331936","phase":"NA","title":"Improving Emotional Regulation Skills of Children in Difficulty in Shenzhen","status":"COMPLETED","sponsor":"City University of Hong Kong","startDate":"2024-01-06","conditions":"Emotion Regulation, Parent-Child Relations, Happiness","enrollment":183},{"nctId":"NCT04314661","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2020-08-03","conditions":"Osteoarthritis, Knee","enrollment":31},{"nctId":"NCT03592329","phase":"NA","title":"Vagus Nerve Stimulation and Stress Reduction Training for Migraine","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-08-20","conditions":"Migraine","enrollment":193},{"nctId":"NCT04203147","phase":"NA","title":"Home-based Diabetes-Modified Behavioral Activation Treatment for Low Income Seniors With T2DM","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2020-01-03","conditions":"Type 2 Diabetes","enrollment":200},{"nctId":"NCT05415267","phase":"PHASE3","title":"Immunosuppression and COVID-19 Boosters","status":"RECRUITING","sponsor":"Kirby Institute","startDate":"2023-07-21","conditions":"COVID-19","enrollment":320},{"nctId":"NCT05997264","phase":"PHASE2","title":"Anthrax AV7909 Boost Evaluation Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2023-12-05","conditions":"Anthrax","enrollment":220},{"nctId":"NCT07074665","phase":"PHASE2","title":"Dose Finding Trial of R21/Matrix-M in School Children","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2026-02-18","conditions":"Malaria (Plasmodium Falciparum)","enrollment":40},{"nctId":"NCT05666167","phase":"NA","title":"Expanding Exercise Programming for Veterans Through Telehealth","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-04-01","conditions":"Arthritis","enrollment":50},{"nctId":"NCT04622150","phase":"NA","title":"Effectiveness RCT of Customized Adherence Enhancement","status":"ACTIVE_NOT_RECRUITING","sponsor":"Case Western Reserve University","startDate":"2022-02-01","conditions":"Bipolar Disorder","enrollment":190},{"nctId":"NCT04317664","phase":"PHASE3","title":"Intervention to Improve Driving Practices Among High-Risk Teen Drivers","status":"COMPLETED","sponsor":"Ginger Yang","startDate":"2020-09-28","conditions":"Drive, Recidivism, Communication","enrollment":240},{"nctId":"NCT04704830","phase":"PHASE3","title":"R21/Matrix-M in African Children Against Clinical Malaria","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2021-04-29","conditions":"Malaria","enrollment":4800},{"nctId":"NCT05587894","phase":"PHASE2","title":"OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial","status":"RECRUITING","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2023-04-27","conditions":"COVID-19, Immunodeficiency","enrollment":256},{"nctId":"NCT05972109","phase":"NA","title":"Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2023-08-01","conditions":"Obesity, Abdominal, Insulin Sensitivity","enrollment":604},{"nctId":"NCT02063724","phase":"PHASE1","title":"HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2014-10-01","conditions":"Breast Cancer","enrollment":15},{"nctId":"NCT07419646","phase":"NA","title":"EmpowerSpine Program","status":"NOT_YET_RECRUITING","sponsor":"Lawson Research Institute of St. Joseph's","startDate":"2026-06-01","conditions":"Internet Delivered Treatment, Spinal Cord Injury, Chronic Pain","enrollment":100},{"nctId":"NCT06815991","phase":"PHASE1","title":"Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults","status":"RECRUITING","sponsor":"Metro International Biotech, LLC","startDate":"2025-02-11","conditions":"Healthy Adults","enrollment":32},{"nctId":"NCT07408687","phase":"NA","title":"Mechanisms Of Change in Psychotherapy: The Effects of Cognitive Behavioral Therapy and Psychodynamic Therapy in Once - Versus Twice - Weekly Sessions on Outcomes in Depression.","status":"NOT_YET_RECRUITING","sponsor":"University of Oslo","startDate":"2026-03-01","conditions":"Depression - Major Depressive Disorder, Cognitive Behavior Therapy, Psychodynamic Therapy","enrollment":200},{"nctId":"NCT06391554","phase":"NA","title":"Effects of EDUcation and EXercise Compared to Education Alone on Clinical and Physiological Outcomes in Patients With Hip Osteoarthritis","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2024-05-01","conditions":"Hip Osteoarthritis","enrollment":150},{"nctId":"NCT07416461","phase":"","title":"Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease","status":"RECRUITING","sponsor":"International Vaccine Institute","startDate":"2025-10-27","conditions":"Invasive Non-Typhoidal Salmonella Disease, Malaria, Malaria Vaccine","enrollment":10000},{"nctId":"NCT07406217","phase":"PHASE2","title":"OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients","status":"RECRUITING","sponsor":"Calmy Alexandra","startDate":"2023-04-27","conditions":"COVID-19, Immunodeficiency","enrollment":256},{"nctId":"NCT04432597","phase":"PHASE1, PHASE2","title":"HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-08-11","conditions":"HPV Positive Cancer, Vulvar, Vaginal, Penile, Rectal Cancer, Anal Cancer","enrollment":39},{"nctId":"NCT02157051","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Washington","startDate":"2015-06","conditions":"HER2 Negative Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIA Breast Cancer","enrollment":42},{"nctId":"NCT05470439","phase":"NA","title":"My Interprofessional Care Team for Adherence and Research Engagement Disparities","status":"RECRUITING","sponsor":"University of Arizona","startDate":"2023-08-30","conditions":"Medication Adherence, Hypertension","enrollment":217},{"nctId":"NCT07406334","phase":"PHASE1","title":"A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose","status":"NOT_YET_RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2026-05-15","conditions":"Pneumonia, Bacterial","enrollment":45},{"nctId":"NCT07406347","phase":"PHASE1","title":"A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age","status":"NOT_YET_RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2026-07-10","conditions":"Pneumonia, Bacterial","enrollment":60},{"nctId":"NCT06789198","phase":"PHASE1","title":"Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA","status":"RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2025-07-08","conditions":"Fibrolamellar Hepatocellular Carcinoma (FLC)","enrollment":20},{"nctId":"NCT04348747","phase":"PHASE2","title":"Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2022-12-19","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Metastatic Triple-Negative Breast Carcinoma","enrollment":23},{"nctId":"NCT03501576","phase":"","title":"Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma","status":"RECRUITING","sponsor":"Emory University","startDate":"2018-04-06","conditions":"Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Booster vaccination","genericName":"Booster vaccination","companyName":"Institute of Tropical Medicine, Belgium","companyId":"institute-of-tropical-medicine-belgium","modality":"Biologic","firstApprovalDate":"","aiSummary":"A booster vaccination reinforces and enhances the immune response by stimulating memory B and T cells to increase antibody production and cellular immunity against a previously encountered pathogen. Used for Booster vaccination for infectious disease prevention (specific pathogen dependent on formulation).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}